These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Changes in in vivo confocal microscopic findings of ocular surface squamous neoplasia during treatment with topical interferon alfa-2b. Zarei-Ghanavati M; Mousavi E; Nabavi A; Latifi G; Mehrjardi HZ; Mohebbi M; Ghassemi H; Mirzaie F; Zare MA Ocul Surf; 2018 Apr; 16(2):235-241. PubMed ID: 29306088 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b. Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223 [TBL] [Abstract][Full Text] [Related]
13. Primary treatment of ocular surface squamous neoplasia with topical interferon alpha-2b: Comparative analysis of outcomes based on original tumor configuration. Shields CL; Constantinescu AB; Paulose SA; Yaghy A; Dalvin LA; Shields JA; Lally SE Indian J Ophthalmol; 2021 Mar; 69(3):563-567. PubMed ID: 33595473 [TBL] [Abstract][Full Text] [Related]
14. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Sturges A; Butt AL; Lai JE; Chodosh J Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690 [TBL] [Abstract][Full Text] [Related]
15. Long term study of topical interferon α-2b eye drops as primary treatment of ocular surface squamous neoplasia. Sripawadkul W; Reyes-Capo D; Zein M; Wylegala A; Albayyat G; Galor A; Karp CL Ocul Surf; 2023 Apr; 28():108-114. PubMed ID: 36592780 [TBL] [Abstract][Full Text] [Related]
16. Topical Chemotherapy for Treating Ocular Surface Squamous Neoplasia with a Combination of Interferon α-2b and 5-Fluorouracil. Geng W; Wang JS; Shi BJ; Xie HT; Zhang MC Ophthalmol Ther; 2022 Aug; 11(4):1563-1576. PubMed ID: 35704159 [TBL] [Abstract][Full Text] [Related]
17. Treatment outcome with interferon alpha 2b in ocular surface squamous neoplasia: Recommendation as primary treatment by peripheral ophthalmologists. Meel R; Dhiman R; Vanathi M; Sen S; Gupta N; Tandon R Oman J Ophthalmol; 2021; 14(1):27-32. PubMed ID: 34084031 [TBL] [Abstract][Full Text] [Related]
18. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Galor A; Karp CL; Chhabra S; Barnes S; Alfonso EC Br J Ophthalmol; 2010 May; 94(5):551-4. PubMed ID: 19493859 [TBL] [Abstract][Full Text] [Related]
19. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia. Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688 [TBL] [Abstract][Full Text] [Related]